Gossamer Bio Inc. (NASDAQ: GOSS) entered into an agreement granting it an option to acquire Respira Therapeutics Inc., a portfolio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE